Gadodiamide-based coronary angiography in a patient with severe renal insufficiency

Journal of Interventional Cardiology

Volumn 18, Issue 5, 2005, Pages 379-383

  Gupta, Rajiv ^a   Uretsky, Barry F ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; BRAIN NATRIURETIC PEPTIDE; DIAGNOSTIC AGENT; GADODIAMIDE; HEMOGLOBIN; IODIXANOL; SODIUM CHLORIDE; TROPONIN I;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD PRESSURE; CASE REPORT; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DOSE RESPONSE; DRUG MIXTURE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HUMAN; HYPERTENSION; IN VITRO STUDY; KIDNEY FAILURE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK FACTOR; THORAX PAIN;

CONTRAST MEDIA; CORONARY ANGIOGRAPHY; GADOLINIUM DTPA; HUMANS; KIDNEY; MALE; MIDDLE AGED; RENAL INSUFFICIENCY; SEVERITY OF ILLNESS INDEX; TRIIODOBENZOIC ACIDS;

EID: 28444490331     PISSN: 08964327     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2005.00073.x     Document Type: Article

References (23)

1. McCullough PA, Wolyn R, Rocher LL, et al. Acute renal failure after coronary intervention: Incidence, risk factors, and relationship to mortality. Am J Med 1997;103:368-375.
2. Gruberg L, Mintz GS, Mehran R, et al. The prognostic implications of further renal function deterioration within 48 hours of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 2000;36:1542-1548.
3. Solomon R, Werner C, Mann D, et al. Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med 1994;331:1416-1420.
4. Birck R, Krzossok S, Markowetz F, et al. Acetylcysteine for prevention of contrast nephropathy: Meta-analysis. Lancet 2003;362:598-603.
5. Rudnick MR, Goldfarb S, Wexler L, et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: A randomized trial. The Iohexol Cooperative Study. Kidney Int 1995;47:254-261.
6. Aspelin P, Aubry P, Fransson SG, et al. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 2003;348:491-499.
7. Sarkis A, Badaoui G, Slaba S, et al. Gadolinium-based coronarography in a patient with renal failure. Catheter Cardiovasc Interv 2001;54:68-69.
8. Sarkis A, Badaoui G, Azar R, et al. Gadolinium-enhanced coronary angiography in patients with impaired renal function. Am J Cardiol 2003;91:974-975.
9. Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced-nephropathy after percutaneous intervention. J Am Coll Cardiol 2004;44:1393-1399.
10. Gupta R, Birnbaum Y, Uretsky BF. The renal patient with coronary artery disease: Current concepts and dilemmas. J Am Coll Cardiol 2004;44:1343-1353.
11. Robert A, Bonneville F, Miralbes S, et al. Gadolinium in arteriography and interventional radiology: 39 patients. J Radiol 2002;83:1759-1763.
12. Ailawadi G, Stanley JC, Williams DM, et al. Gadolinium as a nephrotoxic contrast agent for catheter-based arteriographic evaluation of renal arteries in patients with azotemia. J Vasc Surg 2003;37:346-352.
13. Zeller T, Muller C, Frank U, et al. Gadodiamide as an alternative contrast agent during angioplasty in patients with contraindications to iodinated media. J Endovasc Ther 2002;9:625-632.
14. Bokhari SW, Wen YJ, Winters RJ. Gadolinium-based percutaneous coronary intervention in a patient with renal insufficiency. Catheter Cardiovasc Interv 2003;51:358-361.
15. Bartolini ME, Pekar J, Chettle DR, et al. An investigation of the toxicity of gadolinium based MRI contrast agents using neutron activation analysis. J Magn Reson Imaging 2003;21(5):541-544.
16. Ide JM, Lancelot E, Pines E, et al. Prophylaxis of iodinated contrast media-induced nephropathy: A pharmacological point of view. Invest Radiol 2004;39:155-1570.
17. Nyman U, Elmstahl B, Leander P, et al. Are gadolinium-based contrast media really safer than iodinated media for digital subtraction angiography in patients with azotemia? Radiology 2002;223:311-318.
18. Gemery J, Idelson B, Reid S, et al. Acute renal failure after arteriography with a gadolinium-based contrast agent. Am J Roentgenol 1998;171:1277-1278.
19. Sam AD II, Morasch MD, Collins J, et al. Safety of gadolinium contrast angiography in patients with chronic renal insufficiency. J Vasc Surg 2003;38:313-318.
20. Thomsen HS. Gadolinium-based contrast media may be nephrotoxic even at approved doses. Eur Radiol 2004;14:1654-1656.
21. Thomsen HS, Almen T, Morcos SK. Members of Contrast Media Safety Committee of European Society of Urogenital Radiology. Gadolinium-containing contrast media for radiographic examinations: A position paper. Eur Radiol 2002;12:2600-2605.
22. Manske CL, Sprafka JM, Strony JT, et al. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med 1990;89:615-620.
23. Maddux JT, Wink O, Messenger JC, et al. Randomized study of the safety and clinical utility of rotational angiography versus standard angiography in the diagnosis of coronary artery disease. Catheter Cardiovasc Interv 2004;62(2):167-174.